Get the Stockscreener App
20.51
1.28%
0.26
After Hours:
20.51
Embecta Corp stock is traded at $20.51, with a volume of 601.56K.
It is up +1.28% in the last 24 hours and up +0.39% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$20.25
Open:
$20.22
24h Volume:
601.56K
Relative Volume:
1.64
Market Cap:
$1.19B
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
21.59
EPS:
0.95
Net Cash Flow:
$-30.30M
1W Performance:
-0.92%
1M Performance:
+0.39%
6M Performance:
+69.93%
1Y Performance:
+12.14%
1-Day Range:
$20.02
$20.80
1-Week Range:
$19.98
$21.08
52-Week Range:
$9.925
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
20.51 | 1.19B | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
BDX: 3 Healthcare Innovators Advancing Medical Technology - StockNews.com
Argentina Diabetes Devices Market to Worth Over US$ 1,031.89 Million by 2033 | Astute Analytica - GlobeNewswire Inc.
Embecta Corp. (NASDAQ:EMBC) Stock Position Raised by Barclays PLC - MarketBeat
Geode Capital Management LLC Purchases 45,228 Shares of Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services - Yahoo Finance
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Jane Street Group LLC - MarketBeat
Embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Eagle-Tribune
Embecta To Participate At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Embecta to Present at J.P. Morgan Healthcare Conference 2025: Key Updates Expected - StockTitan
Embecta Corp. Announces Quarterly Cash Dividend, Payable December 18, 2024 - Marketscreener.com
Embecta Corp. (NASDAQ:EMBC) Sees Significant Drop in Short Interest - MarketBeat
Garden State Investment Advisory Services LLC Buys New Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta (EMBC) Passes Through 3% Yield Mark - Nasdaq
Embecta Cutting 100+ Jobs In Andover - Andover News
Meros Investment Management LP Makes New $2.68 Million Investment in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Learn to Evaluate (EMBC) using the Charts - Stock Traders Daily
Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) - MSN
Charles Schwab Investment Management Inc. Has $13.58 Million Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Embecta to cut 125 jobs after ending insulin patch pump - MedTech Dive
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation - Drug Delivery Business News
Ex-Dividend Reminder: TEGNA, Embecta and Popular - Nasdaq
Diabetes company to lay off more than 100 employees in Andover - The Business Journals
New Initiatives Expected To Make Embecta More Profitable (NASDAQ:EMBC) - Seeking Alpha
Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks - MSN
Embecta Corp. appoints new Chief Accounting Officer - Investing.com India
Embecta Corp. appoints new Chief Accounting Officer By Investing.com - Investing.com South Africa
Embecta Corp Appoints Anthony Roth as VP and CAO - TipRanks
Embecta Corp. Announces Executive Changes - Marketscreener.com
Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks (NASDAQ:ISRG) - Seeking Alpha
Embecta Corp (EMBC) Trading Down 3.55% on Dec 2 - GuruFocus.com
New Strong Buy Stocks for December 2nd - MSN
Embecta raised to buy at BTIG after Q4 update - MSN
Embecta upgraded to Equal Weight from Underweight at Morgan Stanley - TipRanks
Embecta to discontinue insulin patch pump program, initiates restructuring plan - MSN
Embecta sees FY25 adjusted EPS $2.70-$2.90, consensus $2.27 - MSN
Embecta (NASDAQ:EMBC) Shares Gap DownShould You Sell? - MarketBeat
Isthmus Partners LLC Has $1.56 Million Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)? - Yahoo Finance
Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15 - Simply Wall St
Algert Global LLC Has $1.48 Million Stake in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
BTIG Upgrades Embecta (EMBC) - MSN
Embecta reports Q4 adjusted EPS 45c, consensus 36c - MSN
Embecta stock outlook brightens with Buy rating on strategic focus and global footprint - Investing.com Canada
Embecta Corp. Reports Earnings Results for the Full Year Ended September 30, 2024 - Marketscreener.com
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
Embecta stock raised to buy at BTIG (EMBC:NASDAQ) - Seeking Alpha
Embecta stock outlook brightens with Buy rating on strategic focus and global footprint By Investing.com - Investing.com South Africa
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):